HSCS (HeartSciences) Cash Flow for Dividends: $0.00 Mil (TTM As of Jan. 2026)


HSCS HeartSciences Inc HSCS
41 GF Score
Price $2.90
GF Value $2.61
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Cash Flow for Dividends?

HeartSciences HSCS -1.18% 41 Cash Flow for Dividends is $0.00 Mil as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 41/100 and a GF Value™ of $2.61 (Modestly Overvalued). The stock has 7 warning signs investors should review.

HeartSciences's cash flow for dividends for the three months ended in Jan. 2026 was $0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Jan. 2026 was $0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

HeartSciences Cash Flow for Dividends Related Terms

HeartSciences Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for HeartSciences's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences Cash Flow for Dividends Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Cash Flow for Dividends
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

HeartSciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HSCS
41GF Score
HeartSciences Inc HSCS
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $0.00 Mil mean?
HeartSciences (HSCS) has a Cash Flow for Dividends of $0.00 Mil as of Jan. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for HeartSciences and its competitors.
Is HeartSciences' Cash Flow for Dividends too high?
HeartSciences' current Cash Flow for Dividends is $0.00 Mil. Overall, HeartSciences has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Cash Flow for Dividends compare to FEED and ITOC?
HeartSciences' Cash Flow for Dividends of $0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for HeartSciences and its competitors. HeartSciences's current Cash Flow for Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.61, compared to a current price of $2.90 — trading 11.1% above its estimated fair value. The current Cash Flow for Dividends is $0.00 Mil. HeartSciences' overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For HeartSciences (HSCS), the current Cash Flow for Dividends is $0.00 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.90 is trading 11.1% above its estimated GF Value™ of $2.61. GuruFocus considers HeartSciences to be Modestly Overvalued.

Key valuation signals for HSCS:

  • Cash Flow for Dividends: $0.00 Mil
  • GF Value™: $2.61 vs. price of $2.90 (11.1% above fair value)
  • GF Score™: 41/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
41GF Score

Get the complete analysis for HSCS

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.90
Price
$2.61
GF Value